VERU - VERU INC.
2.47
-0.090 -3.644%
Share volume: 93,995
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$2.56
-0.09
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 05-08-2024 | 08-08-2024 | 02-13-2025 | 02-13-2025 | 05-08-2025 | 08-12-2025 | 12-17-2025 | 02-11-2026 | |
| Assets | |||||||||
| Total Assets | 71.800 M | 64.632 M | 60.419 M | 39.829 M | 32.672 M | 27.331 M | 29.836 M | 47.567 M | |
| Current Assets | 45.137 M | 38.476 M | 35.223 M | 28.380 M | 21.378 M | 16.193 M | 18.915 M | 36.807 M | |
| Inventories | 4.805 M | 4.942 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.809 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 2.809 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.525 M | 2.405 M | |
| Total Receivables | 2.785 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 34.738 M | 29.151 M | 24.916 M | 26.607 M | 20.018 M | 15.010 M | 15.795 M | 32.991 M | |
| Total Non-current Assets | 26.663 M | 228.824 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.534 M | 1.491 M | 481.372 K | 452.043 K | 422.712 K | 393.381 K | 364.808 K | 336.615 K | |
| Other Assets | 1.320 M | 24.664 M | 24.714 M | 10.996 M | 10.871 M | 10.744 M | 10.556 M | 10.424 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 6.879 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 71.800 M | 64.632 M | 60.419 M | 39.829 M | 32.672 M | 27.331 M | 29.836 M | 47.567 M | |
| Total liabilities | 26.591 M | 27.011 M | 28.102 M | 13.202 M | 11.625 M | 11.986 M | 11.503 M | 10.443 M | |
| Total current liabilities | 9.566 M | 10.620 M | 11.868 M | 6.348 M | 5.619 M | 6.682 M | 7.785 M | 7.128 M | |
| Accounts Payable | 2.464 M | 5.209 M | 2.809 M | 2.530 M | 2.688 M | 2.917 M | 3.516 M | 1.816 M | |
| Other liabilities | 13.762 M | 16.391 M | 16.218 M | 6.853 M | 6.005 M | 5.304 M | 3.718 M | 3.315 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 13.762 M | 16.391 M | 16.218 M | 6.853 M | 6.005 M | 5.304 M | 3.718 M | 3.315 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 45.210 M | 37.620 M | 32.317 M | 26.627 M | 21.047 M | 15.345 M | 18.333 M | 37.124 M | |
| Common stock | 146.381 M | 332.048 M | 335.274 M | 337.949 M | 340.270 M | 341.901 M | 343.435 M | 367.559 M | |
| Retained earnings | -275.070 M | -286.039 M | -294.570 M | -303.515 M | -311.417 M | -318.749 M | -317.296 M | -322.628 M |